Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (11)

1

enthalten in: Der Urologe. Ausg. A | 2020

2

First-line therapy for locally advanced or metastatic urothelial carcinoma : A randomized, controlled phase III trial comparing pembrolizumab with or without platinum-based combination chemotherapy and chemotherapy only in patients with advanced or metastatic urothelial carcinoma (keynote 361-AB 54/16 of the AUO)

enthalten in: Der Urologe. Ausg. A | 2017

von Rexer, H. | Ohlmann, C. | Retz, M.

3

First-line therapy in advanced renal cell carcinoma : A randomized, open-label phase III study evaluating the efficacy and safety of pembrolizumab (MK-3475) in combination with axitinib compared to sunitinib monotherapy as first-line treatment for locally advanced or metastatic renal cell carcinoma (mRCC) (Keynote-426) - AN 39/16 of the AUO

enthalten in: Der Urologe. Ausg. A | 2017

von Rexer, H. | Bedke, J.

4

Adjuvant study of high-risk muscle invasive urothelial carcinoma : Open-label, multicenter, randomized phase III study with atezolizumab (anti-PD-L1 antibody) as adjuvant therapy compared with observation in patients with high-risk muscle invasive urothelial carcinoma after surgical resection (IMvigor010)- study AB 53/15 of the AUO

enthalten in: Der Urologe. Ausg. A | 2016

von Rexer, H. | Retz, M. | Albers, P.

5

First-line treatment for advanced renal cell carcinoma : A phase 3, open-label, randomized study of Atezolizumab (Anti-PD-L1-Antibody) in combination with Bevacizumab versus Sunitinib in patients with untreated advanced renal cell carcinoma ("IMmotion") - AN 37/15 der AUO

enthalten in: Der Urologe. Ausg. A | 2016

von Rexer, H. | Doehn, C.

6

First-line treatment of unresectable, stage IV transitional cell carcinoma

enthalten in: Der Urologe. Ausg. A | 2016

von Rexer, H. | Ohlmann, C.

7

The first antidote is available

enthalten in: MMW Fortschritte der Medizin | 2016

von Bischoff, M.

8

Severe atopic dermatitis. Antibodies revolutionize therapy

enthalten in: MMW Fortschritte der Medizin | 2015

9

Study on therapy of metastasized or locally advanced urothelial cancer : A phase III randomized clinical trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel or vinflunine in subjects with recurrent or progressive metastatic urothelial cancer (Keynote 045) - AP 48/15 der AUO

enthalten in: Der Urologe. Ausg. A | 2015

von Rexer, H.

10

New approaches in LDL cholesterol reduction

enthalten in: MMW Fortschritte der Medizin | 2015

von Füeßl, H.